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Clinical implications of neuroscience research
Anaesthesia and sleep: Where are
we now?
Thomas Gent and Antoine Adamantidis
Abstract
The mechanisms regulating the control of consciousness in both spontaneous sleep–wake behaviour and general
anaesthesia remain poorly understood and are a fundamental question in neuroscience. The last 30 years have identified
numerous molecular substrates and more recently important monoaminergic neuronal substrates. Future work now
needs to concentrate on elucidating the convergence of these neuronal circuits to build a unifying mechanism of
consciousness control.
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Introduction
Sleep is a commonly used analogy for general anaesthesia of
patients and the reasons are easy to appreciate; sleep is a
naturally occurring physiological process characterised by
unconsciousness during which conscious perception of the
external environment is lost whilst self-body perception is
somewhat comparable during oneiric experience. Indeed,
general anaesthesia and natural sleep share many physiologi-
cal hallmarks including an electroencephalogram (EEG) pat-
tern of activity dominated by slow synchronous cortical
waves, body immobility and reduction in core body tempera-
ture,1 but Do they really involve the same neurological pro-
cesses? This concept has enjoyed something of a resurgence
in recent years whereby several hypothalamic sleep-
mediating nuclei have been identified as potential putative
neuronal substrates for general anaesthesia.2–6 Here, we will
summarise these data, focusing on the hypothalamus and
forebrain structures and discuss where future research should
focus to understand better the common and divergent sub-
strates in the brain supporting both sleep, general anaesthesia
and consciousness.
Sleep and anaesthesia: Unknown
mechanisms and common brain
rhythms/shared circuits?
General anaesthetics are a chemically diverse group of mole-
cules sharing a common endpoint: unconsciousness – one of
the critical endpoints for clinical anaesthesia. Their anatomi-
cal targets and the connected underlying neural substrates are
poorlyunderstoodandmaydiffer greatly between agents.1,7–9
Volatile anaesthetics (e.g. halothane and isoflurane) produce
a strongEEG theta rhythm (5–9Hz) analogous to that of rapid
eye movement sleep (REM) sleep. Indeed, pharmacological
inhibition of themedial septumablates theta duringhalothane
anaesthesia,10 similar to optogenetic silencing11 and lesion-
ing12 during REM sleep; however, anaesthetic sensitivity is
not altered, suggesting that consciousness is not under the
control of the medial septum-hippocampus pathway.
GABAergic (gamma-amino butyric acid) agents such as bar-
biturates, alphaxalone and propofol produceEEGslowwaves
(< 4 Hz) and spindles (single, 1 s oscillatory events in the 11–
16 Hz range), suggesting the recruitment of thalamocortical
circuitry. Furthermore, prolonged maintenance of propofol
general anaesthesia can result in EEG signals similar to REM
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sleep. Benzodiazepines (e.g. diazepam and midazolam) pro-
duce a desynchronisedEEGpattern,with little analogy to any
spontaneous sleep EEG rhythms and are considered to have a
direct cortical action given the predominating alpha (7–14
Hz) in the EEGwhich has a cortical origin.13 Ketamine simi-
larly produces a desynchronised EEG and body immobility;
however, there is debate as to whether it is a true general
anaesthetic. Patients given immobilising doses of ketamine
report a dissociative state, consisting of a conscious-like
experience and awareness of their environment,1 suggesting
that consciousness is not lost. One intriguing class of drugs
is the 2-adrenoceptor agonist dexmedetomidine, which
acts selectively at this receptor only, presumably via direct
inhibition of locus coeruleus (LC) neurones,14–16 producing a
heavy but rousable sedation, similar to that of spontaneous
sleep from which subjects may be awoken (unlike hypnosis
with other general anaesthetics in which they may not).
Furthermore, the EEG of patients undergoing dexmedetomi-
dine sedation is highly analogous to stages II and III of non-
rapid eyemovement sleep (NREM),with a high predominance
of spindles and slow waves.17 Interestingly, the expression of
2a adrenoceptors in the brain is highly restricted to the LC,
hypothalamus, claustrumand reticular thalamicnucleus (RTN)
and layer VI of the cortex,18 suggesting it may be a useful tool
to investigate the convergence of spontaneous sleep and gen-
eral anaesthetic relevant brain circuits.
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Figure 1.Molecular targets, EEG signatures and spontaneous sleep analogies of major general anaesthetic agents. Many of the primarily
GABAergic anaesthetics (the notable exception being benzodiazepines) as well as the a2-adrenoceptor agonists produce delta waves
and spindles that bear a striking resemblance to those seen during human NREM stages II and III, suggesting a recruitment of
thalamocortical networks to produce unconsciousness. Volatile anaesthetics exhibit a promiscuous pharmacology with many molecular
targets and a correspondingly high number of proposed neuronal substrates. The EEG of light anaesthesia consists of high theta power,
similar to REM sleep, and shares similar neuronal substrates, such as the medial septum-hippocampal pathway. Ketamine and benzo-
diazepines have non-overlapping pharmacology, yet both produce a desynchronised wake-like EEG and significantly disrupt cortico-
cortical networks.1
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To date, many molecular targets of general anaesthetics
have been identified using both in vitro and in vivo stud-
ies1,19; however, the underlying neuronal mechanisms
remain unclear. The diffuse expression of receptors, partic-
ularly GABAA, two-pore domain potassium channels (K2P)
and n-methyl-d-aspartate (NMDA), throughout the brain
means that identification of many of these targets is unin-
formative as to the changes in brain activity that occur with
alterations in consciousness state.1 Proposed theories for
general anaesthetic mechanisms include hypothalamic inhi-
bition,2–6,20 direct cortical deactivation,7,21 thalamocortical
disruption9,22,23 and interaction with microtubules.24
Several classical sleep–wake regulating hypothalamic
areas have been postulated as putative anaesthetic targets,
in particular the wake-promoting histamine neurones2 and
the sleep-promoting ventrolateral- and median preoptic
(VLPO/MnPO) neurones.4 The first description of this con-
cept demonstrated a GABAergic modulation of the hista-
minergic tuberomamillary nucleus (TMN) which altered
anaesthetic sensitivity.5 In this work, it was proposed that
wake-promoting histamine neurones are indirectly inhib-
ited by the GABAergic acting drugs muscimol, propofol
and pentobarbital. Subsequent work further demonstrated
that cellular activity of TMN, but not adrenergic LC, neu-
rones mirrored the anaesthetic sensitivity demonstrated by
the 3 N265-M mouse.2 This GABAA receptor mutation
reduces in vivo sensitivity to the hypnotic effects of pro-
pofol, as assessed by loss of righting reflex.25 Additionally,
engineering TMN neurones to be sensitive to the sleep-
promoting drug zolpidem results in reduced latency and
increased duration of sleep6 suggesting that the TMN may
be a common substrate for spontaneous sleep and general
anaesthesia. However, removing GABAA receptors from
histamine neurones in mice (a genetic manipulation to
release inhibition of these cells and render them more exci-
table) does not alter propofol sensitivity, suggesting that the
TMN is not central to general anaesthetic mechanisms.3
On the other hand, the sleep-promoting GABAergic
neurones of the preoptic hypothalamus play a central role
in the flip-flop model of sleep–wake control.26 Within this
area, there are sleep- and wake-active GABAergic neu-
rones, of which only the sleep-active ones are activated
by volatile anaesthetics including halothane and isoflur-
ane.27 Furthermore, genetic ablation of these neurones
leads to in vivo resistance to the hypnotic effects of iso-
flurane whereas their inhibition facilitates arousal.28 In line
with these studies, the VLPO, a small subset of inhibitory
neurones located in the anterior hypothalamus, has also
been shown to be a key neural substrate for both the sleep
homeostatic process and sedation by dexmedetomidine an
2 adrenergic agonist,
4 a drug which produces electrophy-
siological EEG slow waves and spindles17 and behavioural
(rousable sedation)18 states very similar to natural sleep.
Besides these two targets, the hypothalamus contains
neuronal populations that are selectively active during
sleep and wakefulness. These include melatonin
concntrating hormone (MCH), vesicular GABA/glycine
transporter (VGAT) and Hcrt/Ox neurones that have been
causally involved in sleep29,30 and arousal,31–34 respec-
tively. Although the relationship between MCH and Hcrt/
Ox neurones and anaesthesia remains unknown, optoge-
netic silencing of arousal-promoting GABAergic lateral
hypothalamus (LHVGAT) neurones is key for sleep stability,
sleep homeostasis and deep anaesthesia.34 Accordingly,
optogenetic activation of LHVGAT neurones during deep
isoflurane anaesthesia (revealed by burst-suppression in
the EEG) rapidly induced a sustained cortical arousal and
often, a recovery of muscle tone, signalling emergence
from anaesthesia and recovery of loss of righting reflex
(LORR), which is interpreted as a first step towards
regaining of consciousness in animals. This suggests that
a proper silencing of these cells is required for stable
anaesthesia.
Several of the wake-promoting hypothalamic nuclei
have been identified as potential putative anaesthetic
targets.1,2,4–6,14,20 The heterogeneity and complex wiring
diagram of hypothalamic neurones have, so far, hampered
our understanding of the neurobiological mechanisms
underlying brain control of sleep, wake and anaesthesia.
Yet, their participation in either the EEG hallmarks or the
progressive loss of consciousness associated with general
anaesthesia requires further investigation since they project
to arousal-promoting cell groups where they may inhibit
noradrenergic, serotonergic, cholinergic, histaminergic and
hypocretinergic neurones,35 as previously suggested by the
‘reciprocal inhibitory’ model of the sleep–wake switch.36
Beyond hypothalamic circuits
Many of the sleep–wake regulating hypothalamic nuclei
project extensively to the thalamus,34,37,38 neocortex6,20,33
and basal forebrain39; however, it is yet to be established
how hypothalamic perturbation by general anaesthetics
results in unconsciousness; What is their anatomical
target? Answering this question will be crucial to under-
standing mechanisms of sleep, general anaesthesia and
consciousness.
Very few studies have addressed whether either the tha-
lamus or the neocortex are putative anaesthetic targets,
which contrasts with their direct implication of cortical
EEG patterns of activity. Studies in vitro show that anaes-
thetics can alter thalamic and cortical neuronal activity,
often by increasing potassium conductance,40,41 but this
does not help to explain their behaviour within a network.
Both thalamus and cortex show bursting activity during
sleep and general anaesthesia rather than being silenced
which requires that the neurones are first hyperpo-
larised.42,43 Whether this occurs via a direct action on the
neurones themselves or as a result of retarded ascending
arousal pathways remains unclear.
Human studies using fMRI show that activity of the
thalamus is commonly suppressed during general
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anaesthesia induced by different agents leading to the the-
ory of a thalamic switch.44,45 However, others suggest that
thalamic activity is merely a read out of cortical activity7,21
owing to the reciprocal connectivity between thalamus and
cortex. A more informative angle of investigation might be
to consider how thalamocortical connectivity is perturbed
during changes in conscious state.8 One theory of con-
sciousness formation comes from the large-scale informa-
tion integration in the neocortex,46 a process which may be
disrupted by general anaesthetics8 and natural sleep.47,48
Interestingly, integration across frontal and occipital areas
appears to be crucial to consciousness giving rise the parieto-
occipital ‘hotspot’ where preferential activation of the EEG
occurs during conscious experience.49 Furthermore, dream
recall (considered to be a form of consciousness during
sleep) following spontaneous sleep is associated with
increased EEG frequency in the same areas.50
The role of the thalamus in orchestrating the integration
of information in the neocortex is still a matter of debate.
Studies in animals have demonstrated that cortical state is
determined by thalamic activity51,52 and that highly loca-
lised thalamic activation may result in emergence from
anaesthesia.34,40,53–55 Furthermore, lesions of the central
thalamus in humans result in disorders of conscious-
ness.56–58 Interestingly, activity of the dorsal thalamus, an
area involved in multisensory integration,59,60 is disrupted
in Schizophrenia where conscious perception is often per-
turbed.61,62 However, extensive lateral thalamic lesions in
rats do not result in unconsciousness, whereas lesioning of
the basal forebrain produces coma.63 While this may dis-
miss a role for thalamus in conscious control, the lateral
sensory thalamus only has control of small localised corti-
cal regions and does not receive ascending arousal connec-
tions.60,64 Furthermore, sensory information relayed by the
sensory thalamus may reach the primary sensory cortex
during all vigilance states,65 suggesting that gating of sen-
sory information during unconsciousness occurs elsewhere
in the thalamus.
The thalamus is a functionally heterogeneous region60,66
suggesting that distinct thalamic nuclei may be important
for the regulation of consciousness.23,40,57 Sensory evoked
potentials can be elicited in primary sensory cortices during
natural sleep,65 anaesthesia67,68 and vegetative state,69 sug-
gesting that connectivity between sensory thalamus and
cortex is not disrupted during unconsciousness. Data from
animals23,67,70,71 and humans22,68,72–74 indicate that disrup-
tion of higher order, but not primary, thalamocortical con-
nectivity is responsible for loss of consciousness observed
in both general anaesthesia and natural sleep. Furthermore,
the higher order and midline thalamus have been shown to
integrate sensory information in the cortex66,75–77 as well as
receiving multiple ascending arousal inputs,78–80 which the
lateral sensory thalamus does not. In accordance with this,
activation of the midline thalamus increases awareness in
coma patients56 and can result in anaesthetic emergence in
animals.40,53
Taken together, these data implicate thalamocortical cir-
cuitry in the control of consciousness and sleep. It remains
to be determined how this circuitry is modulated to switch
between wakefulness and spontaneous sleep or general
anaesthesia.
Perspectives
To date, there is a considerable volume of observational
work on the mechanisms of natural sleep and general
anaesthesia. Most of these have identified common path-
ways in the hypothalamus and pons where targeting of
regions is relatively straight forward. These identified tar-
gets are further consistent with the varying degree of auto-
nomic disturbance produced by different general
anaesthetics. Perturbational approaches to determine the
mechanisms of consciousness are still in their infancy.
Important insights have been gleamed from altering mole-
cular expression in hypothalamic nuclei in animal models;
however, this work is yet to be extended to investigate the
neural substrates at the thalamic and cortical level which
are necessary for consciousness. Furthermore, most of the
work has focused on altering anaesthetic sensitivity by tar-
geting wake-promoting neurones. Experimental wake-
promoting circuit evoked emergence from anaesthesia does
not implicate these as putative anaesthetic targets. In that
sense, it would be interesting to investigate whether sleep-
promoting systems either prolong, deepen or hasten the
onset of general anaesthesia. Indeed, many anaesthetics
exhibit hysteresis with regard to induction and recovery,81
suggesting that different mechanisms are responsible for
each process. A greater understanding of the circuit
mechanisms involved in modulation of the thalamus and
cortex is needed to design experiments to interrogate the
thalamocortical networks underpinning sleep, general
anaesthesia and consciousness.
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